ID   RIPK3_HUMAN             Reviewed;         518 AA.
AC   Q9Y572; B4DJL9; C4AM87; Q5J795; Q5J796; Q6P5Y1;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-SEP-2008, sequence version 2.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Receptor-interacting serine/threonine-protein kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=RIP-like protein kinase 3;
DE   AltName: Full=Receptor-interacting protein 3;
DE            Short=RIP-3;
GN   Name=RIPK3; Synonyms=RIP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), MUTAGENESIS OF LYS-50, AND
RP   INTERACTION WITH RIPK1.
RC   TISSUE=Cervix carcinoma, and Lymphocyte;
RX   PubMed=10339433; DOI=10.1016/S0960-9822(99)80239-5;
RA   Yu P.W., Huang B.C.B., Shen M., Quast J., Chan E., Xu X., Nolan G.P.,
RA   Payan D.G., Luo Y.;
RT   "Identification of RIP3, a RIP-like kinase that activates apoptosis
RT   and NFkappaB.";
RL   Curr. Biol. 9:539-542(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF LYS-50.
RC   TISSUE=Aortic endothelium, and Fetal brain;
RX   PubMed=10358032; DOI=10.1074/jbc.274.24.16871;
RA   Sun X., Lee J., Navas T., Baldwin D.T., Stewart T.A., Dixit V.M.;
RT   "RIP3, a novel apoptosis-inducing kinase.";
RL   J. Biol. Chem. 274:16871-16875(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15896315; DOI=10.1016/j.bbrc.2005.04.114;
RA   Yang Y., Hu W., Feng S., Ma J., Wu M.;
RT   "RIP3 beta and RIP3 gamma, two novel splice variants of receptor-
RT   interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 332:181-187(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   RIP HOMOTYPIC INTERACTION MOTIF, PHOSPHORYLATION AT SER-199, AND
RP   INTERACTION WITH RIPK1.
RX   PubMed=11734559; DOI=10.1074/jbc.M109488200;
RA   Sun X., Yin J., Starovasnik M.A., Fairbrother W.J., Dixit V.M.;
RT   "Identification of a novel homotypic interaction motif required for
RT   the phosphorylation of receptor-interacting protein (RIP) by RIP3.";
RL   J. Biol. Chem. 277:9505-9511(2002).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH PYGL; GLUL AND GLUD1.
RX   PubMed=19498109; DOI=10.1126/science.1172308;
RA   Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., Dong M.Q.,
RA   Han J.;
RT   "RIP3, an energy metabolism regulator that switches TNF-induced cell
RT   death from apoptosis to necrosis.";
RL   Science 325:332-336(2009).
RN   [10]
RP   FUNCTION, PHOSPHORYLATION AT SER-199, AND INTERACTION WITH RIPK1.
RX   PubMed=19524512; DOI=10.1016/j.cell.2009.05.021;
RA   He S., Wang L., Miao L., Wang T., Du F., Zhao L., Wang X.;
RT   "Receptor interacting protein kinase-3 determines cellular necrotic
RT   response to TNF-alpha.";
RL   Cell 137:1100-1111(2009).
RN   [11]
RP   FUNCTION.
RX   PubMed=19524513; DOI=10.1016/j.cell.2009.05.037;
RA   Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M.,
RA   Chan F.K.;
RT   "Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates
RT   programmed necrosis and virus-induced inflammation.";
RL   Cell 137:1112-1123(2009).
RN   [12]
RP   REVIEW.
RX   PubMed=20354226; DOI=10.1126/scisignal.3115re4;
RA   Vandenabeele P., Declercq W., Van Herreweghe F., Vanden Berghe T.;
RT   "The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.";
RL   Sci. Signal. 3:RE4-RE4(2010).
RN   [13]
RP   UBIQUITINATION BY BIRC2/C-IAP1 AND BIRC3/C-IAP2, AND INTERACTION WITH
RP   BIRC2/C-IAP1; BIRC3/C-IAP2 AND XIAP/BIRC4.
RX   PubMed=21931591; DOI=10.1371/journal.pone.0022356;
RA   Bertrand M.J., Lippens S., Staes A., Gilbert B., Roelandt R.,
RA   De Medts J., Gevaert K., Declercq W., Vandenabeele P.;
RT   "cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin
RT   chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).";
RL   PLoS ONE 6:E22356-E22356(2011).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH MLKL, PHOSPHORYLATION
RP   AT SER-227, ACTIVE SITE, AND MUTAGENESIS OF ASP-142 AND SER-227.
RX   PubMed=22265413; DOI=10.1016/j.cell.2011.11.031;
RA   Sun L., Wang H., Wang Z., He S., Chen S., Liao D., Wang L., Yan J.,
RA   Liu W., Lei X., Wang X.;
RT   "Mixed lineage kinase domain-like protein mediates necrosis signaling
RT   downstream of RIP3 kinase.";
RL   Cell 148:213-227(2012).
RN   [15]
RP   FUNCTION, IDENTIFICATION IN COMPLEX WITH PGAM5; RIPK1 AND MLKL, AND
RP   MUTAGENESIS OF LYS-50.
RX   PubMed=22265414; DOI=10.1016/j.cell.2011.11.030;
RA   Wang Z., Jiang H., Chen S., Du F., Wang X.;
RT   "The mitochondrial phosphatase PGAM5 functions at the convergence
RT   point of multiple necrotic death pathways.";
RL   Cell 148:228-243(2012).
RN   [16]
RP   INTERACTION WITH ARHGEF2.
RX   PubMed=21887730; DOI=10.1002/ibd.21851;
RA   Zhao Y., Alonso C., Ballester I., Song J.H., Chang S.Y., Guleng B.,
RA   Arihiro S., Murray P.J., Xavier R., Kobayashi K.S., Reinecker H.C.;
RT   "Control of NOD2 and Rip2-dependent innate immune activation by GEF-
RT   H1.";
RL   Inflamm. Bowel Dis. 18:603-612(2012).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH MLKL.
RX   PubMed=22421439; DOI=10.1073/pnas.1200012109;
RA   Zhao J., Jitkaew S., Cai Z., Choksi S., Li Q., Luo J., Liu Z.G.;
RT   "Mixed lineage kinase domain-like is a key receptor interacting
RT   protein 3 downstream component of TNF-induced necrosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:5322-5327(2012).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-300 AND GLN-492.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Essential for necroptosis, a programmed cell death
CC       process in response to death-inducing TNF-alpha family members.
CC       Upon induction of necrosis, RIPK3 interacts with, and
CC       phosphorylates RIPK1 and MLKL to form a necrosis-inducing complex.
CC       RIPK3 binds to and enhances the activity of three metabolic
CC       enzymes: GLUL, GLUD1, and PYGL. These metabolic enzymes may
CC       eventually stimulate the tricarboxylic acid cycle and oxidative
CC       phosphorylation, which could result in enhanced ROS production.
CC       {ECO:0000269|PubMed:19498109, ECO:0000269|PubMed:19524512,
CC       ECO:0000269|PubMed:19524513, ECO:0000269|PubMed:22265413,
CC       ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:22421439}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts (via RIP homotypic interaction motif) with
CC       RIPK1 (via RIP homotypic interaction motif); this interaction
CC       induces RIPK1 phosphorylation and formation of a RIPK1-RIPK3
CC       necrosis-inducing complex. Upon TNF-induced necrosis, the RIPK1-
CC       RIPK3 dimer further interacts with PGAM5 and MLKL; the formation
CC       of this complex leads to PGAM5 phosphorylation and increase in
CC       PGAM5 phosphatase activity. Interacts with MLKL; the interaction
CC       is direct. Binds TRAF2 and is recruited to the TNFR-1 signaling
CC       complex. Interacts with PYGL, GLUL and GLUD1; these interactions
CC       result in activation of these metabolic enzymes. Interacts with
CC       BIRC2/c-IAP1, BIRC3/c-IAP2 and XIAP/BIRC4. Interacts with ARHGEF2.
CC       {ECO:0000269|PubMed:10339433, ECO:0000269|PubMed:11734559,
CC       ECO:0000269|PubMed:19498109, ECO:0000269|PubMed:19524512,
CC       ECO:0000269|PubMed:21887730, ECO:0000269|PubMed:21931591,
CC       ECO:0000269|PubMed:22265413, ECO:0000269|PubMed:22265414,
CC       ECO:0000269|PubMed:22421439}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-298250, EBI-298250;
CC       Q13490:BIRC2; NbExp=3; IntAct=EBI-298250, EBI-514538;
CC       Q13489:BIRC3; NbExp=3; IntAct=EBI-298250, EBI-517709;
CC       Q8NB16:MLKL; NbExp=10; IntAct=EBI-298250, EBI-1055040;
CC       Q13546:RIPK1; NbExp=26; IntAct=EBI-298250, EBI-358507;
CC       Q8IXJ6:SIRT2; NbExp=2; IntAct=EBI-298250, EBI-477232;
CC       Q9H171:ZBP1; NbExp=4; IntAct=EBI-298250, EBI-6264672;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:22265413}. Cell membrane {ECO:0000250}.
CC       Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y572-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=Q9Y572-2; Sequence=VSP_035106;
CC       Name=3; Synonyms=Gamma;
CC         IsoId=Q9Y572-3; Sequence=VSP_035107;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the pancreas. Detected at
CC       lower levels in heart, placenta, lung and kidney. Isoform 3 is
CC       significantly increased in colon and lung cancers.
CC       {ECO:0000269|PubMed:15896315}.
CC   -!- PTM: RIPK1 and RIPK3 undergo reciprocal auto- and trans-
CC       phosphorylation. Phosphorylation of Ser-199 plays a role in the
CC       necroptotic function of RIPK3. Phosphorylation at Ser-227 is
CC       required for binding MLKL. {ECO:0000269|PubMed:11734559,
CC       ECO:0000269|PubMed:19524512, ECO:0000269|PubMed:22265413}.
CC   -!- PTM: Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by
CC       BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-
CC       B. {ECO:0000269|PubMed:21931591}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF156884; AAD39005.1; -; mRNA.
DR   EMBL; AY453693; AAS16359.1; -; mRNA.
DR   EMBL; AY494982; AAS75516.1; -; mRNA.
DR   EMBL; AY494983; AAS75517.1; -; mRNA.
DR   EMBL; AL096870; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK296140; BAG58881.1; -; mRNA.
DR   EMBL; CH471078; EAW66021.1; -; Genomic_DNA.
DR   EMBL; BC062584; AAH62584.1; -; mRNA.
DR   CCDS; CCDS9628.1; -. [Q9Y572-1]
DR   RefSeq; NP_006862.2; NM_006871.3. [Q9Y572-1]
DR   UniGene; Hs.268551; -.
DR   ProteinModelPortal; Q9Y572; -.
DR   SMR; Q9Y572; -.
DR   BioGrid; 116224; 24.
DR   DIP; DIP-27519N; -.
DR   IntAct; Q9Y572; 14.
DR   MINT; MINT-1131399; -.
DR   STRING; 9606.ENSP00000216274; -.
DR   BindingDB; Q9Y572; -.
DR   ChEMBL; CHEMBL1795199; -.
DR   iPTMnet; Q9Y572; -.
DR   PhosphoSitePlus; Q9Y572; -.
DR   BioMuta; RIPK3; -.
DR   DMDM; 205371831; -.
DR   PaxDb; Q9Y572; -.
DR   PeptideAtlas; Q9Y572; -.
DR   PRIDE; Q9Y572; -.
DR   DNASU; 11035; -.
DR   Ensembl; ENST00000216274; ENSP00000216274; ENSG00000129465. [Q9Y572-1]
DR   Ensembl; ENST00000554756; ENSP00000452328; ENSG00000129465. [Q9Y572-3]
DR   GeneID; 11035; -.
DR   KEGG; hsa:11035; -.
DR   UCSC; uc001wpb.4; human. [Q9Y572-1]
DR   CTD; 11035; -.
DR   DisGeNET; 11035; -.
DR   GeneCards; RIPK3; -.
DR   HGNC; HGNC:10021; RIPK3.
DR   HPA; HPA055087; -.
DR   MIM; 605817; gene.
DR   neXtProt; NX_Q9Y572; -.
DR   OpenTargets; ENSG00000129465; -.
DR   PharmGKB; PA34396; -.
DR   eggNOG; KOG0192; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00550000074536; -.
DR   HOGENOM; HOG000035101; -.
DR   HOVERGEN; HBG062538; -.
DR   InParanoid; Q9Y572; -.
DR   KO; K08847; -.
DR   OMA; VTKFMEN; -.
DR   OrthoDB; EOG091G0DXD; -.
DR   PhylomeDB; Q9Y572; -.
DR   TreeFam; TF106506; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1810476; RIP-mediated NFkB activation via ZBP1.
DR   Reactome; R-HSA-2562578; TRIF-mediated programmed cell death.
DR   Reactome; R-HSA-3295583; TRP channels.
DR   Reactome; R-HSA-5213460; RIPK1-mediated regulated necrosis.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   SignaLink; Q9Y572; -.
DR   SIGNOR; Q9Y572; -.
DR   GeneWiki; RIPK3; -.
DR   GenomeRNAi; 11035; -.
DR   PRO; PR:Q9Y572; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000129465; -.
DR   CleanEx; HS_RIPK3; -.
DR   ExpressionAtlas; Q9Y572; baseline and differential.
DR   Genevisible; Q9Y572; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097342; C:ripoptosome; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004704; F:NF-kappaB-inducing kinase activity; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IMP:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0032147; P:activation of protein kinase activity; IMP:UniProtKB.
DR   GO; GO:1990000; P:amyloid fibril formation; IMP:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0048535; P:lymph node development; ISS:UniProtKB.
DR   GO; GO:0070266; P:necroptotic process; IMP:UniProtKB.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0051351; P:positive regulation of ligase activity; IEA:Ensembl.
DR   GO; GO:0060545; P:positive regulation of necroptotic process; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0051353; P:positive regulation of oxidoreductase activity; IEA:Ensembl.
DR   GO; GO:0010922; P:positive regulation of phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0090312; P:positive regulation of protein deacetylation; IEA:Ensembl.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0046006; P:regulation of activated T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0070235; P:regulation of activation-induced cell death of T cells; ISS:UniProtKB.
DR   GO; GO:0002819; P:regulation of adaptive immune response; ISS:UniProtKB.
DR   GO; GO:2000452; P:regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation; ISS:UniProtKB.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; ISS:UniProtKB.
DR   GO; GO:0001914; P:regulation of T cell mediated cytotoxicity; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0048536; P:spleen development; ISS:UniProtKB.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB.
DR   GO; GO:0043029; P:T cell homeostasis; ISS:UniProtKB.
DR   GO; GO:0048538; P:thymus development; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR025735; RHIM_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF12721; RHIM; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Cytoplasm; Kinase; Membrane; Mitochondrion; Necrosis;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1    518       Receptor-interacting serine/threonine-
FT                                protein kinase 3.
FT                                /FTId=PRO_0000086610.
FT   DOMAIN       21    287       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      27     35       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       450    466       RIP homotypic interaction motif (RHIM).
FT   COMPBIAS    357    448       Pro-rich.
FT   ACT_SITE    142    142       Proton acceptor.
FT                                {ECO:0000305|PubMed:22265413}.
FT   BINDING      50     50       ATP.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   MOD_RES     164    164       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   MOD_RES     199    199       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11734559,
FT                                ECO:0000269|PubMed:19524512}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000269|PubMed:22265413}.
FT   MOD_RES     252    252       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   MOD_RES     299    299       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   MOD_RES     333    333       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   MOD_RES     389    389       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   MOD_RES     401    401       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9QZL0}.
FT   VAR_SEQ     220    518       VELPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKE
FT                                LMQLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTV
FT                                KDFLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRND
FT                                VMVSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAW
FT                                TAGTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGN
FT                                QGAERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNY
FT                                LTMQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAW
FT                                SRPQGWYNHSGK -> CQPNHHSCTKQCATGRTGLHWLSCP
FT                                KPGLRLPA (in isoform 2).
FT                                {ECO:0000303|PubMed:15896315}.
FT                                /FTId=VSP_035106.
FT   VAR_SEQ     222    518       LPTEPSLVYEAVCNRQNRPSLAELPQAGPETPGLEGLKELM
FT                                QLCWSSEPKDRPSFQECLPKTDEVFQMVENNMNAAVSTVKD
FT                                FLSQLRSSNRRFSIPESGQGGTEMDGFRRTIENQHSRNDVM
FT                                VSEWLNKLNLEEPPSSVPKKCPSLTKRSRAQEEQVPQAWTA
FT                                GTSSDSMAQPPQTPETSTFRNQMPSPTSTGTPSPGPRGNQG
FT                                AERQGMNWSCRTPEPNPVTGRPLVNIYNCSGVQVGDNNYLT
FT                                MQQTTALPTWGLAPSGKGRGLQHPPPVGSQEGPKDPEAWSR
FT                                PQGWYNHSGK -> CKTLGGFWDP (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15896315}.
FT                                /FTId=VSP_035107.
FT   VARIANT     260    260       E -> V (in dbSNP:rs7153640).
FT                                /FTId=VAR_051664.
FT   VARIANT     300    300       T -> M (in dbSNP:rs34106261).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041048.
FT   VARIANT     492    492       P -> Q (in dbSNP:rs3212254).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041049.
FT   MUTAGEN      50     50       K->A: Abolishes kinase activity. Loss of
FT                                PGAM5- and MLKL-binding. No effect on
FT                                RIPK1-binding.
FT                                {ECO:0000269|PubMed:10339433,
FT                                ECO:0000269|PubMed:10358032,
FT                                ECO:0000269|PubMed:22265414}.
FT   MUTAGEN      50     50       K->D: Abolishes kinase activity.
FT                                {ECO:0000269|PubMed:10339433,
FT                                ECO:0000269|PubMed:10358032,
FT                                ECO:0000269|PubMed:22265414}.
FT   MUTAGEN     142    142       D->N: Abolishes kinase activity and
FT                                ability to mediate necroptosis.
FT                                {ECO:0000269|PubMed:22265413}.
FT   MUTAGEN     227    227       S->A: Abolishes ability to mediate
FT                                necroptosis.
FT                                {ECO:0000269|PubMed:22265413}.
FT   CONFLICT     30     30       G -> D (in Ref. 1; AAD39005).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       L -> P (in Ref. 1; AAD39005).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       R -> K (in Ref. 1; AAD39005).
FT                                {ECO:0000305}.
SQ   SEQUENCE   518 AA;  56887 MW;  BF755F8A0B1810A1 CRC64;
     MSCVKLWPSG APAPLVSIEE LENQELVGKG GFGTVFRAQH RKWGYDVAVK IVNSKAISRE
     VKAMASLDNE FVLRLEGVIE KVNWDQDPKP ALVTKFMENG SLSGLLQSQC PRPWPLLCRL
     LKEVVLGMFY LHDQNPVLLH RDLKPSNVLL DPELHVKLAD FGLSTFQGGS QSGTGSGEPG
     GTLGYLAPEL FVNVNRKAST ASDVYSFGIL MWAVLAGREV ELPTEPSLVY EAVCNRQNRP
     SLAELPQAGP ETPGLEGLKE LMQLCWSSEP KDRPSFQECL PKTDEVFQMV ENNMNAAVST
     VKDFLSQLRS SNRRFSIPES GQGGTEMDGF RRTIENQHSR NDVMVSEWLN KLNLEEPPSS
     VPKKCPSLTK RSRAQEEQVP QAWTAGTSSD SMAQPPQTPE TSTFRNQMPS PTSTGTPSPG
     PRGNQGAERQ GMNWSCRTPE PNPVTGRPLV NIYNCSGVQV GDNNYLTMQQ TTALPTWGLA
     PSGKGRGLQH PPPVGSQEGP KDPEAWSRPQ GWYNHSGK
//
